Suppr超能文献

证据表明,在接受抗反转录病毒治疗后免疫反应不佳的 HIV 感染患者的外周血液中存在多种微生物菌群转移。

Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.

机构信息

Department of Medicine, Surgery and Dentistry, Clinic of Infectious Diseases, San Paolo Hospital, University of Milan, Milan, Italy.

出版信息

PLoS One. 2011 Apr 11;6(4):e18580. doi: 10.1371/journal.pone.0018580.

Abstract

In advanced HIV infection, the homeostatic balance between gastrointestinal indigenous bacteria and gut immunity fails and microbes are able to overcome the intestinal barrier and gain the systemic circulation. Because microbial translocation is not fully controlled by antiviral therapy and is associated with inefficient CD4+ reconstitution, we investigated the profile of translocating bacteria in peripheral blood of 44 HIV-infected patients starting therapy with advanced CD4+ T-lymphopenia and displaying poor CD4+ recovery on virologically suppressive HAART. According to CD4+ reconstitution at 12-months HAART, patients were considered Partial Immunological Responders, PIRs (CD4+≥250/µl, n = 29) and Immunological non Responders, INRs (CD4+<200/µl, n = 15)). We show that PIRs and INRs present similarly elevated plasma levels of lipopolysaccharide (LPS) and its ligand sCD14 that were not lowered by virologically suppressive therapy. Bacterial 16S rRNA gene amplification and sequencing resulted in a highly polymicrobic peripheral blood microbiota both prior and after 12-month HAART. Several differences in bacterial composition were shown between patients' groups, mainly the lack of probiotic Lactobacillaceae both prior and after therapy in INRs. Failure to control microbial translocation on HAART is associated with a polymicrobic flora circulating in peripheral blood that is not substantially modified by therapy.

摘要

在晚期 HIV 感染中,胃肠道本土细菌和肠道免疫之间的稳态平衡被打破,微生物能够突破肠道屏障并进入全身循环。由于微生物易位不能被抗病毒治疗完全控制,并且与 CD4+ 重建效率低下有关,我们研究了在开始治疗时 CD4+ 淋巴细胞减少处于晚期且在病毒抑制性 HAART 下 CD4+ 恢复不佳的 44 名 HIV 感染患者的外周血中易位细菌的特征。根据 HAART 治疗 12 个月时的 CD4+ 重建情况,将患者分为部分免疫应答者(PIRs,CD4+≥250/µl,n=29)和免疫无应答者(INRs,CD4+<200/µl,n=15)。我们发现,PIRs 和 INRs 的血浆脂多糖(LPS)及其配体 sCD14 水平同样升高,而病毒抑制性治疗并不能降低这些水平。16S rRNA 基因扩增和测序显示,在 HAART 治疗前后,外周血微生物群都高度多样化。在患者组之间显示出几种细菌组成的差异,主要是 INRs 组在治疗前后缺乏益生菌乳杆菌科。HAART 治疗未能控制微生物易位与循环在外周血中的多微生物菌群有关,而治疗并不能实质性地改变这些菌群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc82/3073938/d205d05cfa29/pone.0018580.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验